| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 9 | |
| #2 | United States | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Computer technology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Analysing materials | |
| #5 | Bioinformatics | |
| #6 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Sancenon Vicente | 2 |
| #2 | Ingram Piers | 2 |
| #3 | Boyd-Kirkup Jerome Douglas | 2 |
| #4 | Paszkiewicz Konrad | 2 |
| #5 | Guan Siyu | 2 |
| #6 | Wu Zhihao | 2 |
| #7 | Thakkar Dipti | 2 |
| Publication | Filing date | Title |
|---|---|---|
| US2019300610A1 | Vista antigen-binding molecules | |
| GB201817354D0 | Engineered FC | |
| GB201814562D0 | Vista antigen-binding molecules | |
| GB201804066D0 | Antagonism of MDSCs through antagonism of VISTA | |
| GB201720426D0 | CD47 and BCMA antigen-binding molecules | |
| GB201720425D0 | CD47 and CD33 antigen-binding molecules | |
| GB201720028D0 | Antigen-binding molecule format | |
| GB201718101D0 | CD47 and CD33 Antigen-binding molecules | |
| GB201512039D0 | Immunization method | |
| GB201511112D0 | Epitope prediction |